Charles Schwab Investment Management Inc Ironwood Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,539,430 shares of IRWD stock, worth $6.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,539,430
Previous 1,392,403
10.56%
Holding current value
$6.96 Million
Previous $12.1 Million
17.23%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$97.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$74.1 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$41.8 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$40.3 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $693M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...